Precision T1D Platform - New Therapies for Cardio-Renal Complications
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Finerenone
Related studies linked through entity extraction aliases.
Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE4
Finerenone Plus SGLT2 Inhibitors in Heart Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Finerenone and Cardiac Remodeling
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
- Status
- RECRUITING
- Phase
- PHASE4
Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
- Status
- RECRUITING
- Phase
- NA
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
- Status
- RECRUITING
- Phase
- N/A
Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis
- Status
- RECRUITING
- Phase
- PHASE2
Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease
- Status
- RECRUITING
- Phase
- PHASE4
Effect of Finerenone in IgA Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy
- Status
- COMPLETED
- Phase
- N/A
The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4